CoChat
Sign Up
Cited by 65Fungal Infections and StudiesActinomycetales infections and treatmentAntifungal resistance and susceptibility

Coccidioidomycosis in African Americans

Open access
Ruddy, Barbara E., Mayer, Anita P., Ko, Marcia G., Labonte, Helene R., Borovansky, Jill A., Boroff, Erika S., Blair, Janis E.·2011·Mayo Clinic Proceedings
DOI 10.4065/mcp.2010.0423PMC PMC3012635
Open this paper in CoChat — free account

Abstract

Coccidioidomycosis is caused by Coccidioides species, a fungus endemic to the desert regions of the southwestern United States, and is of particular concern for African Americans. We performed a PubMed search of the English-language medical literature on coccidioidomycosis in African Americans and summarized the pertinent literature. Search terms were coccidioidomycosis, Coccidioides, race, ethnicity, African, black, and Negro. The proceedings of the national and international coccidioidomycosis symposia were searched. All relevant articles and their cited references were reviewed; those with epidemiological, immunologic, clinical, and therapeutic data pertaining to coccidioidomycosis in African Americans were included in the review. Numerous studies documented an increased predilection for severe coccidioidal infections, coccidioidomycosis-related hospitalizations, and extrapulmonary dissemination in persons of African descent; however, most of the published studies are variably problematic. The immunologic mechanism for this predilection is unclear. The clinical features and treatment recommendations are summarized. Medical practitioners need to be alert to the possibility of coccidioidomycosis in persons with recent travel to or residence in an area where the disease is endemic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4065/mcp.2010.0423

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HLA class II antigens HLA-A9 and HLA-B9 and ABO blood type B have been associated with more severe coccidioidomycosis infection, although it is unclear if the association is causal or due to an increased proportion of these phenotypes in Filipino and black or African American individuals.

    “Human leukocyte antigens (HLA) class II antigens (HLA-A9 and HLA-B9 antigens) and ABO blood type B have been associated with more severe coccidioidomycosis infection, although it is unclear if there is a causal association or if this association is merely due to an increased proportion of these phenotypes in Filipino and black or African American individuals [44,45].”

    From Race and ethnicity: Risk factors for fungal infections? (2023) · cites this paper as [45]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. [12]12. US Census Bureau State and county quickfacts Web site. Washington, DC: Arizona quickfacts from the U.S. Census Bureau; 2008. http://quickfacts.census.gov/qfd/states/04000.html Accessed November 2, 2010 [Google Scholar]
  2. [13]13. Arizona Department of Health Services Phoenix, AZ: Arizona Department of Health Services; 2009. http://www.azdhs.gov Updated 05/05/09 Accessed November 2, 2010 [Google Scholar]
  3. [14]14. Arizona Department of Health Services Infectious disease epidemiology: coccidioidomycosis: general information. Phoenix, AZ: Arizona Department of Health Services; 2008. http://www.azdhs.gov/phs/oids/epi/disease/cocci/index.htm Accessed November 2, 2010 [Google Scholar]
  4. [19]19. Anstead GM, Graybill JR. Coccidioidomycosis. Infect Dis Clin North Am. 2006;20:621-643 [DOI] [PubMed] [Google Scholar]
  5. [20]20. Fiese MJ. Coccidioidomycosis. Springfield, IL: Charles C. Thomas; 1958:13-15 [Google Scholar]
  6. [24]24. Crum NF, Lederman ER, Stafford CM, Parrish JS, Wallace MR. Coccidioidomycosis: a descriptive survey of a reemerging disease: clinical characteristics and current controversies. Medicine (Baltimore). 2004;83(3):149-175 [DOI] [PubMed] [Google Scholar]
  7. [27]27. Gifford MA, Buss WC, Douds RJ. Annual report: Kern County Department of Public Health for the fiscal year July 1, 1936 to June 30, 1937. In: Annual Report (Kern County [Calif.]. Health Dept.). Bakersfield, CA: Kern County Dept. of Public Health; 1937:47-52 [Google Scholar]
  8. [32]32. Arsura EL, Caldwell J, Johnson R, et al. Coccidioidomycosis epidemic of 1991: epidemiologic features. In: Einstein HE, ed. Coccidioidomycosis: Proceedings of the 5th International Conference on Coccidioidomycosis, Stanford University, 24-27 August 1994: Centennial Conference. Bethesda, MD: National Foundation for Infectious Diseases; 1996:98-107 [Google Scholar]

Cited by

Sorted by citations

Related

Authors
Ruddy, B. E., Mayer, A. P., Ko, M. G., Labonte, H. R., Borovansky, J. A., Boroff, E. S., & Blair, J. E.
Affiliations
  • Mayo Clinic (US)
  • Mayo Clinic in Arizona (US)
Corresponding author
Ruddy, Barbara E.
ORCID
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2011-01
Volume
86
Issue
1
Pages
63-69
ISSN
0025-6196 (ISSN-L)
DOI
10.4065/mcp.2010.0423
PMC
PMC3012635
OpenAlex
W2103183303
Cited by
65
References
51
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 6 · 2012: 4
FWCI
0.44
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Mayo Clinic Proceedings (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Microbiology › Actinomycetales infections and treatment
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
coccidioidomycosis, Coccidioides, African Americans, ethnic predisposition, extrapulmonary dissemination, clinical features, antifungal therapy, travel-associated infection, endemic fungal disease
MeSH terms
Black or African American, Coccidioidomycosis, Humans, Risk Factors, Travel, United States, Incidence, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review